Application of Akkermansia muciniphila in the aspect of treating chronic pancreatitis
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- JIANGNAN UNIV
- Publication Date
- 2021-06-11
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention discloses the application of Akkermansia muciniphila in treating chronic pancreatitis, in particular relates to the application of Akkermansia muciniphila BAA-835 strain in treating chronic pancreatitis, and belongs to the application field of probiotics. Background technique
[0002] Chronic pancreatitis is a multifactorial inflammatory pancreatic disease that can cause irreversible damage to pancreatic tissue and function. The main pathogenic factors of chronic pancreatitis are alcoholism, smoking, high-fat and high-protein diet, genetic factors and so on. At present, chronic pancreatitis affects 1 / 2000 of the world's population, and 13% of chronic pancreatitis patients will progress to pancreatic cancer, which has a serious impact on the lives of patients. The clinical manifestations of chronic pancreatitis are various, and the pathogenesis is not fully clear, so there is no effective drug for the treatment of chronic pancreatitis. T...